Target intelligence / Profile preview

Kinesin motor protein

Molecular classification
Motor protein, Enzyme (ATPase), Transporter (molecular transporter for cellular cargo)
01

Overview

Kinesin motor proteins are a superfamily of ATP-dependent molecular motors that move unidirectionally along microtubules to transport cellular cargo, including organelles, vesicles, and proteins, and to participate in critical processes such as mitosis and meiosis[1][3][5][6][8]. Kinesins are typically composed of two heavy chains, forming dimeric or tetrameric complexes, and contain a conserved motor (head) domain that binds both microtubules and nucleotides, as well as variable coiled-coil stalks and cargo-binding tail regions[2][3][8]. Force for motility is generated by ATP hydrolysis in the head domain, enabling movement toward the microtubule plus end (anterograde transport), though some kinesins mediate retrograde movement or have non-motile functions[1][3][5][6][8]. Kinesin motor proteins are essential for cell viability; dysfunction or mutation is associated with neurodegenerative and mitotic diseases, and inhibition of mitotic kinesins is an active area of cancer therapeutics development[6][9].

Other names
KinesinKinesin superfamily proteinKIF (for specific members, e.g., KIF1A)Microtubule-based motor protein
02

Mechanism of action

Inhibition of ATPase activity (prevents energy transduction and movement along microtubules) Inhibition of microtubule binding or "walking" (arrests cargo transport and mitosis) Stabilization of inactive conformations (prevents the conformational changes required for motility)

03

Biological functions

Intracellular transport (organelle, vesicle, and protein trafficking)Mitosis (spindle assembly, chromosome segregation)MeiosisCytoskeleton organization and maintenanceCell division
04

Disease associations

CancerNeurodegenerative disease (e.g., hereditary spastic paraplegia, Charcot-Marie-Tooth disease)Infection (certain viral pathogenesis exploits kinesins)Other (generic cellular dysfunction, axonal transport disorders)
05

Safety considerations

Neurological toxicity (especially with pan-kinesin inhibitors)Myelosuppression (due to inhibition of dividing cells)Off-target effects on non-mitotic transport in differentiated cells
06

Interacting drugs

Ispinesib (SB-715992)

4 more in the full profile.

07

Biomarkers

KIF11 (Eg5) expression levels in tumors (potential mitotic marker)Kinesin-1 mutations (for specific hereditary neuropathies)

Beyond the preview

Go deeper on Kinesin motor protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinesin motor protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call